1. 1315PDevelopment and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study. (23rd October 2018) Authors: Garcia-Carbonero, R; Alonso, V; Capdevila, J; Sanchez Canovas, M; Alonso, T; Benavent, M; Custodio, A; Crespo Herrero, G; Lopez, C; Hernando, J; Riesco Martinez, M C; Escudero, P; Gallego Plazas, J; Marazuela, M; Diaz, J A; Llanos-Munoz, M; La Casta, A; Percovich, J C; Jimenez-Fonseca, P; Carmona... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CP-117 Use and effectiveness of firstline chemotherapy regimens in advanced gastric cancer: evolution from 2009 to 2016. (25th February 2017) Authors: Manceñido, FJ Alvarez; Palomo, A Rodriguez; Garcia, I Zapico; de Prado, JM Vieitez; Lorenzo, ML Sanchez; Arrojo, S Fernandez; Garcia, L Faez; Hernandez, MP Solis; Jimenez-Fonseca, P; Carmona-Bayonas, A Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗